A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effects

R. Marolda, F. Belli, A. Prada, F. Villani, C. Gambacorti-Passerini, A. Galazka, G. Parmiani, N. Cascinelli

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)575-584
Number of pages10
JournalTumori
Volume73
Issue number6
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Cancer Research

Cite this

Marolda, R., Belli, F., Prada, A., Villani, F., Gambacorti-Passerini, C., Galazka, A., Parmiani, G., & Cascinelli, N. (1987). A phase I study of recombinant interleukin 2 in melanoma patients. Toxicity and clinical effects. Tumori, 73(6), 575-584.